Cover Image
市場調查報告書

醫藥品原料藥(API)的美國市場

Active Pharmaceutical Ingredients (API) Market in the US 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 324081
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
醫藥品原料藥(API)的美國市場 Active Pharmaceutical Ingredients (API) Market in the US 2015-2019
出版日期: 2015年02月04日 內容資訊: 英文 65 Pages
簡介

醫藥品原料藥(API),是有醫藥品的製造所使用的有藥理效果的活性物質。美國的API市場,從2014年到2019年之間,預計以7.01%的年複合成長率(CAGR)擴大。

本報告提供美國的醫藥品原料藥(API)市場現狀及今後的成長預測調查、各製造工程及各治療領域的市場規模與其預測、市場成長因素與課題、並提供主要企業簡介等資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要

第7章 美國的API市場

  • 市場規模與預測
  • 出口和國內消費
  • 波特的五力分析

第8章 各製造工程類型的市場區隔

第9章 各治療領域的市場區隔

  • 抗感染疾病
  • 心血管及造血系
  • 中樞神經系統
  • 腸胃及肝膽道系
  • 呼吸系統
  • 腫瘤

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
  • 主要供應商的排行榜
  • 其他卓越供應商

第18章 主要供應商分析

  • Aurobindo Pharma
  • Cipla
  • Dr. Reddy's Laboratories

第19章 相關報告

目錄
Product Code: IRTNTR5191

About API

Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.

TechNavio's analysts forecast the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).

The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

  • Abbott Laboratories
  • Aurobindo Pharma
  • Mylan
  • Teva Pharmaceutical Industries

Other Prominent Vendors

  • Albemarle
  • Aptuit
  • BASF
  • Biocon
  • Boehringer Ingelheim
  • Cambrex
  • Cipla
  • Dr. Reddy's Laboratories
  • Hospira
  • Lonza Group
  • Novartis
  • Pfizer
  • Sigma-Aldrich
  • Sun Pharmaceutical Industries

Market Driver

  • Strong Preference for Generic Drugs
  • For a full, detailed list, view our report

Market Challenge

  • Decrease in R&D Spending
  • For a full, detailed list, view our report

Market Trend

  • Strong Focus on High-potency API
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview

07. API Market in the US

  • 07.1. Market Size and Forecast
  • 07.2. Five Forces Analysis

08. Market Segmentation by Type of Production Process

09. Market Segmentation by Type of Product

10. Market Segmentation by Type of Players

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
  • 18.2. Key Vendors 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories Inc.
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Aurobindo Pharma
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation
    • 19.2.4. Geographical Segmentation by Revenue 2014
    • 19.2.5. Business Strategy
    • 19.2.6. Recent Developments
    • 19.2.7. SWOT Analysis
  • 19.3. Mylan
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Business Segmentation by Revenue 2013
    • 19.3.4. Business Segmentation by Revenue 2011-2013
    • 19.3.5. Geographical Segmentation by Revenue 2013
    • 19.3.6. Business Strategy
    • 19.3.7. Recent Developments
    • 19.3.8. SWOT Analysis
  • 19.4. Teva Pharmaceutical Industries
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation
    • 19.4.4. Business Segmentation by Revenue 2013
    • 19.4.5. Business Segmentation by Revenue 2012 and 2013
    • 19.4.6. Sales by Geography
    • 19.4.7. Business Strategy
    • 19.4.8. Key Developments
    • 19.4.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Segmentation of the API Market in US
  • Exhibit 3: Segmentation of the API Market in US by Type of Production Process
  • Exhibit 4: Segmentation of the API Market in US by Type of Product
  • Exhibit 5: Segmentation of the API Market in US by Type of Players
  • Exhibit 6: API Market in the US 2014-2019 (US$ billion)
  • Exhibit 7: Segmentation of API Market in US by Technology 2014
  • Exhibit 8: Segmentation of the API Market in US by Type of Product 2014
  • Exhibit 9: Segmentation of the API Market in US by Type of Players 2014
  • Exhibit 10: Small Molecule Drugs: Patent Expiry during 2013-2016
  • Exhibit 11: Abbott Laboratories Inc.: Business Segmentation
  • Exhibit 12: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 13: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 14: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 15: Aurobindo Pharma: Business Segmentation
  • Exhibit 16: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
  • Exhibit 17: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2013
  • Exhibit 18: Active Pharmaceutical Ingredients (API) Market in the US: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 19: Active Pharmaceutical Ingredients (API) Market in the US: Geographical Segmentation by Revenue 2013
  • Exhibit 20: Teva Pharmaceutical Industries: Business Segmentation
  • Exhibit 21: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
  • Exhibit 22: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 23: Teva Pharmaceutical Industries: Sales by Geography 2013
Back to Top